|
A significant advantage of our technology is that it is readily adaptable to developing vaccine products against many types of infectious disease. We are interested in establishing industry and academic partnerships to help fulfill the potential of these technologies.
These relationships may include:
- Collaborations with organizations with expertise in specific disease areas with the goal of co-developing products.
- Agreements for the marketing and distribution of products.
- Sub-licensing agreements for product development.
To further explore partnering opportunities with Najít Technologies, please contact
Mark Slifka, Ph.D. at info@najittech.com.
|
|
|
